Selected Publications

Bevers M, Booraem C, Li K, Sreekrishnan A, Sastre C, Falcone GJ, Sheth KN, Sansing LH, Kimberly WT. Association of Soluble ST2 With Functional Outcome, Perihematomal Edema, and Immune Response After Intraparenchymal Hemorrhage. Neurology, in press, (2022).

Bhave VM, Ament Z, Patki A, Gao Y, Kijpaisalratana N, Guo B, Chaudhary NS, Guarniz AG, Gerszten R, Correa A, Cushman M, Judd S, Irvin MR, Kimberly WT. Plasma Metabolites Link Dietary Patterns to Stroke Risk. Ann Neurol, in press, (2022).

Irvine HJ, Acharjee A, Wolcott Z, Ament Z, Hinson HE, Molyneaux BJ, Simard JM, Sheth KN, Kimberly WT. Hypoxanthine is a pharmacodynamic marker of ischemic brain edema modified by glibenclamide. Cell Rep Med, 3:100654 (2022).

Yuen MM, Prabhat AM, Mazurek MH, Chavva IR, Crawford A, Cahn BA, Beekman R, Kim JA, Gobeske KT, Petersen NH, Falcone GJ, Gilmore EJ, Hwang DY, Jasne AS, Hardik A, Sharma R, Matouk C, Ward A, Schindler J, Sansing L, de Havenon A, Aydin A, Wira C, Sze G, Rosen MS, Kimberly WT, Sheth KN. Sci. Adv., 8:eabm3952 (2022).

Ament Z, Patki A, Chaudhary N, Bhave VM, Garcia Guarniz AL, Gao Y, Gerszten RE, Correa A, Judd SE, Cushman M, Long ML, Irvin RM, Kimberly WT. Neurology, 98:e2097-e2107 (2022).

Schleicher RL, Bevers MB, Rubin DB, Koch MJ, Bache S, Lissak IA, Patel AB, Rosenthal ES, Møller K, Kimberly WT. Stroke, 52(8):e494-e496, (2021).

Ament Z, Bevers MB, Wolcott Z, Kimberly WT, Acharjee A. Transl Stroke Res,12:293-302 (2021).

Sheth KN, Mazurek MH, Yuen MM, Cahn BA, Shah JT, Kim JA, Gilmore EJ, Falcone GJ, Petersen N, Gobeske KT, Kaddouh F, Hwang DY, Rothberg J, Sze G, Siner J, Rosen MS, Spudich S, and Kimberly WT. JAMA Neurol, 78:41-47 (2021).

Lissak IA, Sahar ZF, Westover BM, Schleicher RL, Kim JA, Leslie-Mazwi T, Stapleton CJ, Patel AB, Kimberly WT and Rosenthal ES. Stroke, 51:1128-1134 (2020).

Bevers MB, Wolcott Z, Bache S, Hansen C, Sastre C, Mylvaganam R, Koch MJ, Patel AB, Møller K and Kimberly WT. Ann Neurol, 83:384-394 (2019).